Hydrocortisone cream - Fougera Pharmaceuticals

Drug Profile

Hydrocortisone cream - Fougera Pharmaceuticals

Alternative Names: Hydrocortisone 0.1% cream; Hydrocortisone buteprate; Hydrocortisone probutate cream; Pandel

Latest Information Update: 20 Nov 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fougera Pharmaceuticals
  • Class Corticosteroids; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Skin disorders

Most Recent Events

  • 05 Nov 2015 Accelis Pharma agrees to promote hydrocortisone probutate in USA for Skin disorders
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top